TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia
Stem Cell Investigation · 26.09.2016 · 3 · 50-50
DOI: 10.21037/sci.2016.09.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Investigation, online erschienen am 26.09.2016. Verfasst von Yajuan Cui und 16 weiteren Autor:innen. Beteiligte Einrichtung: MDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin …. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China;; State Key Laboratory of Experimental Hematology, Insti…
- Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou 310000, China.
- Department of Hematology, Guangdong General Hospital, Guangzhou 510010, China.
- Hematology Research Center, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK.
- MDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
- State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Zitieren
APA
Cui, Y., Tong, H., Du, X., Li, B., Gale, R. P., Qin, T., Liu, J., Xu, Z., Zhang, Y., Huang, G., Jin, J., Fang, L., Zhang, H., Pan, L., Hu, N., Qu, S., & Xiao, Z. (2016). TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia. Stem Cell Investigation, 3, 50-50. https://doi.org/10.21037/sci.2016.09.04
Vancouver
Cui Y, Tong H, Du X, Li B, Gale RP, Qin T, et al. TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia. Stem Cell Investigation. 2016;3:50-50. doi:10.21037/sci.2016.09.04
BibTeX
@article{Cui2016,
author = {Cui, Yajuan and Tong, Hongyan and Du, Xin and Li, Bing and Gale, Robert Peter and Qin, Tiejun and Liu, Jinqin and Xu, Zefeng and Zhang, Yue and Huang, Gang and Jin, Jie and Fang, Liwei and Zhang, Hongli and Pan, Lijuan and Hu, Naibo and Qu, Shiqiang and Xiao, Zhijian},
title = {TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia},
journal = {Stem Cell Investigation},
year = {2016},
volume = {3},
pages = {50--50},
doi = {10.21037/sci.2016.09.04}
}
EUVIMED